( 2 ) metabolic myocardial radiopharmaceuticals have the potential to identify metabolic alterations unique to a given intrinsic cardiac disease ( e.g . cardiomyopathies ) , to assess acute metabolic changes or in delineating a specific chronic metabolic defect ( e.g . coronary artery disease ) .
C0018799
cardiac
C0878544
cardiomyopathies